Evidence map›Paper›PMID 27682013›Full record

ArticleImmunobiology2017

Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases.

Gen Kano, Bruce S Bochner, Nives Zimmermann

Abstract read
In one paragraph

Article in Immunobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Enigma of Eosinophil Degranulation.International journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Gen KanoDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, United States; Department of Pediatrics, Kyoto Prefecture University of Medicine, Japan.
Bruce S BochnerDivision of Allergy-Immunology, Northwestern University Feinberg School of Medicine, United States.
Nives ZimmermannDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, United States; Department of Pathology and Laboratory Medicine, University of Cincinnati, United States. Electronic address: nives.zimmermann@cchmc.org.
Cincinnati Children's Hospital Medical Center · USNorthwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Targeting Siglec-8/Siglec-F Reduce Allergic Responses In Vitro and In VivoR01AI072265 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BOCHNER, BRUCE S · 2007 to 2017
$3.9M
Molecular Mechanism of Eosinophil Cell DeathR21AI103853 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI ZIMMERMANN, NIVES · 2013 to 2014
$409k
NCI NIH HHS P30 CA060553NIAID NIH HHS R01 AI072265NIAID NIH HHS R21 AI103853NIDDK NIH HHS P30 DK078392
6 · The paper itself

Abstract

rationaleSiglec-8 is a surface receptor predominantly expressed on human eosinophils where its ligation induces reactive oxygen species (ROS) formation and cell death. Since Siglec-8 has intracellular tyrosine-based motifs, we hypothesized that Src family kinases (SFKs) are involved in ROS formation and cell death induced by Siglec-8 engagement.

methodsHuman peripheral blood eosinophils were purified and incubated with anti-Siglec-8 monoclonal antibodies (mAb, agonist), IL-5, and SFK pharmacological inhibitors. We focused on Siglec-8-induced cell death in short-term IL-5-activated cells leading to a regulated necrosis-type cell death. ROS production was determined by dihydrorhodamine (DHR) 123 labeling and flow cytometry, or by chemiluminescence using Amplex red. Activation of SFK was determined using phospholuminex and Western blotting.

resultsIn order to determine cellular localization of ROS production, we measured intra and extracellular ROS. While an ETosis stimulus (calcium ionophore A23187) led to extracellular ROS (ecROS) production, Siglec-8-engagement in short-term IL-5 activated cells led to intracellular ROS (icROS) accumulation. Consistently, inhibition of extracellular ROS by catalase inhibited ETosis, but not IL-5-primed Siglec-8-induced cell death. In order to determine signaling events for Siglec-8, we performed Western blotting and found SFK phosphorylation in lysates from eosinophils stimulated with anti-Siglec-8 mAb±IL-5. In order to identify which SFKs were involved, we used the phospholuminex assay and found increased levels of phosphorylated Fgr in the cytoplasmic fraction of cells co-stimulated with anti-Siglec-8 and IL-5 for 3 hours compared with cells stimulated with IL-5 alone. To test the involvement of SFKs in ROS production and cell death, we used SFK inhibitors PP2 and dasatinib, both of which completely inhibited eosinophil ROS production and cell death induced by anti-Siglec-8 and IL-5 co-stimulation.

conclusionSiglec-8 engagement in short-term IL-5-activated eosinophils causes icROS production and SKF phosphorylation, and both are essential in mediating Siglec-8-induced cell death.

Indexed as

Antigens, CDAntigens, Differentiation, B-LymphocyteCell DeathCells, CulturedEosinophilsHumansInterleukin-5LectinsPhosphorylationProtein Kinase InhibitorsReactive Oxygen SpeciesSignal Transductionsrc-Family KinasesAntigens, CDAntigens, Differentiation, B-LymphocyteInterleukin-5LectinsProtein Kinase InhibitorsReactive Oxygen SpeciesSIGLEC8 protein, humansrc-Family KinasesCell deathEosinophils

Identifiers

PMID27682013
PMCPMC5154890
OpenAlexW2523396300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.